News

NanoGroup S.A. Shareholders Approve Share Issue at PLN 4.20 in Connection with the Acquisition of Auxilius Pharma S.A.

NanoGroup S.A. shareholders have adopted all resolutions required to proceed with the transaction involving Auxilius Pharma S.A. The Company has received a…

Auxilius Pharma Takes Another Step Forward in the Development of AUX-001

Auxilius Pharma S.A., a biotechnology company set to join the NanoGroup, has signed an agreement with French CDMO Skyepharma for the manufacture of cl…

Shareholders Holding 35.84% of Voting Rights Enter into Voting Agreement Ahead of NanoGroup EGM, Marking Another Step Towards the Integration of Auxilius Pharma into the Group

On 25 August 2026, NanoGroup shareholders representing a total of 35.84% of the total voting rights entered into an agreement to vote in con…

NanoGroup Begins Preparing NanOX for Entry into the U.S. Market, Appointing a Dedicated Team Led by Dr Habil. Tomasz Zastawny

NanoGroup S.A. is beginning preparations for the potential entry of its flagship NanOX System project into the U.S. market. The Company has appointed a ded…

NanoGroup Calls Extraordinary General Meeting for 26 August: Another Step Towards Finalising the Auxilius Pharma Transaction

NanoGroup Calls Extraordinary General Meeting for 26 August: Another Step Towards Finalising the Auxilius Pharma Transaction

The Management Board of NanoGroup S.A. has convened an Extraordinary General Meeting (EGM) for 26 August 2026, marking another stage in the implementation …

NanoGroup S.A. Selects a CRO and Begins the Large-Animal Preclinical Study Phase of NanOX 4 Kidney

Polish perfusion technology enters an advanced stage of preclinical validation in kidney transplantation. NanoGroup S.A., a Polish biotechnology compa…

Media resources

Company logo

logotype.zip (1.27 MB)
Download
pp-thumbnail